You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
雲頂新耀(01952.HK)完成先舊後新配售股份 籌資約15.53億港元
格隆匯 08-01 19:40

格隆匯8月1日丨雲頂新耀(01952.HK)公吿,根據配售及認購協議的條款及條件,配售事項已於2025年7月30日完成,其中合共22,561,000股待售股份已由配售代理盡力成功配售予不少於六名承配人,每股待售股份的購買價為69.70港元。

由於完成認購事項的所有條件已達成,故公司根據配售及認購協議的條款及條件於2025年8月1日按每股認購股份69.70港元配發及發行22,561,000股認購股份予賣方。

認購事項所得款項淨額約為1,553.39百萬港元。公司擬將認購事項所得款項淨額按下列方式動用︰(i)50%(約776.69百萬港元)用於管線產品的全球研發,例如進一步開發具有自主知識產權的mRNA技術平台及在腫瘤及自體免疫疾病領域的管線資產,以及全球臨牀開發EVER001,EVER001為用於治療原發性膜性腎病及其他自體免疫所引致腎病的BTK抑制劑管線產品等;(ii)40%(約621.36百萬港元)用於持續商業化推進工作,包括在公司授權區域內將依嘉®、耐賦康®及伊曲莫德等新產品上市,以及集團供應鏈拓展與優化等;及(iii)10%(約155.34百萬港元)用作營運資金及一般行政管理用途,包括一般業務營運、業務發展等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account